Approved Pilot and Failed Pivotal Study [Study As­sess­ment]

posted by kumarnaidu – Mumbai, India, 2015-12-08 08:02 (3847 d 04:25 ago) – Posting: # 15706
Views: 18,791

Dear all,

Recently I came across the situation where pilot study passed and pivotal study failed. The different batches of reference drug were used in both the study due to unavailability.

Pilot study (3 way reference replicate): N = 21
Cmax-99.8 (87.8 - 113.4) and AUC-99.9 (88.2 - 113.2)

Pivotal study (3 way reference replicate): N = 42
Cmax-83.3 (77.2 - 89.9) and AUC-85.2 (79.0 - 91.9)

Here I compared reference and test drug used in pilot and pivotal study

Reference
Cmax- Pivotal/Pilot = 127.2 (105.3 - 153.6)
AUC- Pivotal/Pilot = 112.5 (91.9 - 137.7)

Test
Cmax- Pivotal/Pilot = 107.2 (89.4 - 128.6)
AUC- Pivotal/Pilot = 96.7 (78.7 - 118.7)

From the above data can we say that the reference drug used in pivotal study shows more release as compared to the used in pilot study? And I think this can be the probable reason for failure of pivotal study.:confused:

Please give your suggestions.

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
201 visitors (0 registered, 201 guests [including 69 identified bots]).
Forum time: 13:27 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5